Therapeutic play-based guidance for children with pneumonia: Impact on treatment compliance, anxiety, and fear

Figure 1  Flowchart of patient screening.

Figure 2 Comparative anxiety and fear evaluations. A: Screen for Child Anxiety-Related Emotional Disorders-based anxiety assessment across groups; B: Child Medical Fear Scale-based fear assessment across groups. ^aP < 0.05, ^bP < 0.01 vs baseline; ^cP < 0.05 vs control. SCARED: Screen for Child Anxiety-Related Emotional Disorders; CMFS: Child Medical Fear Scale.

Figure 3 Comparative assessment of symptom resolution. A: Time to cough resolution across the research and control groups; B: Time to expectoration resolution across groups; C: Time to wheezing resolution across groups; D: Time to fever resolution across the study groups. ^aP < 0.05 vs control.

Figure 4 Comparative pulmonary function evaluation. A: Forced expiratory volume levels across the research and control groups; B: Vital capacity levels across groups; C: Maximal voluntary ventilation levels in both cohorts; D: Peak expiratory flow levels across the research and control groups. ^aP < 0.05, ^bP < 0.01 vs baseline; ^cP < 0.05 vs control. FEV: Forced expiratory volume; VC: Vital capacity; MVV: Maximal voluntary ventilation; PEF: Peak expiratory flow.